Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls

Toxicology and Applied Pharmacology

Volumn 167, Issue 3, 2000, Pages 157-172

  DeVito, M J ^a   Menache M G ^b   Diliberto, J J ^a   Ross, D G ^a   Birnbaum, L S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Dioxins; Polychlorinated biphenyls; Relative potency; Toxic Equivalency Factors

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3,3',4,4',5 PENTACHLOROBIPHENYL; ETHOXYRESORUFIN DEETHYLASE; PHENACETIN O DEETHYLASE; POLYCHLORINATED BIPHENYL DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HEALTH HAZARD; LIVER; LUNG; MOUSE; NONHUMAN; SKIN;

ANIMALIA; ERAGROSTIS TEF; ZEA MAYS;

EID: 0034665825     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.9010     Document Type: Article

References (43)

1. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection
2. Toxic equivalency factors for dioxin-like PCBs: Report on a WHO-ECEH and IPCS consultation, December 1993
3. Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment
4. Benchmark Dose Workshop: Criteria for use of a benchmark dose to estimate a reference dose
5. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus
6. Evidence for the role of the Ah receptor in response to dioxin
7. TEFs: A practical approach to a real-world problem
8. Disposition of octachlorodibenzo-p-dioxin (OCDD) in male rats
9. Use of toxic equivalency factors for risk assessment for dioxin and related compounds
10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
11. Disposition and excretion of 2,3,4,7,8-pentachlorodibenzofuran in the rat
12. Interactions of persistent environmental organohalogens with the thyroid hormone system: Mechanisms and possible consequences for animal and human health
13. Phenobarbital induces cytochrome P4501A2 hnRNA, mRNA and protein in the liver of C57BL/6J wild type and aryl hydrocarbon receptor knock-out mice
14. Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin (OCDD) during a 13-week study
15. Distribution and excretion of 2,3,7,8-tetrachlorodibenzofuran in C57BL/6J and DBA/2J mice
16. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin
17. The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran
18. Dose-response relationships for polyhalogenated dioxin and dibenzofurans following subchronic treatment in mice: I. Cyp1a1 and Cyp1a2 enzyme activity in liver, lung and skin
19. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation
20. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment
21. Dose-response relationships for disposition and hepatic sequestration of polyhalogenated dibenzo-p-dioxin, dibenzofurans, and biphenyls following subchronic treatment in mice
22. Role of CYP1A2 in hepatic sequestration of dioxin: Studies using CYP1A2 knock-out mice
23. Effects of CYP1A2 on disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2',4,4',5,5'-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice
24. Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures
25. Relative tumor promoting activity of three polychlorinated biphenyls in rat liver
26. Kinetics of pharmacologic response
27. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8- tetrachlorodibenzo-p-dioxin in the rat: Biliary excretion and induction of cytochromes CYP1A1 and CYP1A2
28. Role of cytochrome P450 IA2 in acetanilide 4-hydroxylation as determined with cDNA expression and monoclonal antibodies
29. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonists for the Ah receptor
30. [125I]2-Iodo-3,7,8,-trichlorodibenzo-p-dioxin binding species in mouse liver induced by agonists for the Ah receptor: Characterization and indentification
31. Estimating relative potency for receptor-mediated toxicity: Reevaluating the toxicity equivalence factor (TEF) model
32. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs)
33. Polychlorinated biphenyls (PCBs): Environmental impact biochemical and toxic responses and implications for risk assessment
34. Chlorinated dioxins and dibenzofurans in human tissue from general populations: A selective review
35. Polychlorinated biphenyl levels in the tissues of exposed and nonexposed humans
36. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element
37. The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness
38. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife
39. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity
40. Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity
41. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is a tight binding inhibitor of cytochrome P-450d
42. Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse